New Drug Shows Promise in Treating Ovarian Cancer
The experimental drug olaparib, which has been shown to be effective in treating ovarian cancer in patients with BRCA1 or BRCA2 gene mutations, also appears to work in some patients...
Click here to read the full story.
No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.
The content has been reported and it will be reviewed by a moderator.